A Novel Small Molecule Oral Therapeutic to Prevent and Reverse Skeletal Muscle Atrophy in Aging Adults

Project: Research project

Project Details

Description

Dr. Gugala will be responsible for conducting and interpreting microCT analyses of bone (femur) specimens to assess bone volume, mineral density, and microarchitecture. Dr. Gugala will conduct the proposed research in his laboratory at UTMB.
StatusFinished
Effective start/end date9/1/238/31/24

Funding

  • Ridgeline Therapeutics, LLC ( Award #1R43AG08446001A1): $39,035.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.